NURO neurometrix.com: Nilai perusahaan marang pendapatan

Limited pricing power due to low insurance coverage makes demand elastic, which impacts the business valuation based on EV/Sales. The value shows the current magnitude of this metric. NeuroMetrix, Inc. (NURO) is developing Quell to combat neuropathy amid a growing market for non-pharmacological pain relief. Direct mailing of devices to patients minimizes clinic costs and stabilizes logistics.
NURO (NeuroMetrix Corporation): rincian analitis lan laporan miturut indikator

This indicator measures the enterprise value of the business minus net debt per unit of sales, reflecting the sensitivity of capitalization to operational efficiency. Stable electronics supplies for NeuroMetrix, Inc. (NURO) support profitability, allowing the EV/Revenue ratio on GURU.Markets to be used for identifying trend reversals and extreme valuation points prior to the publication of financial statements.